Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Herrmann

Showing results (451-460 of 477) with videos related to

Pageof 48
Sort By:
The Review of Scientific Instruments|December 2, 2024
Inferring fusion nuclear burnwidths with low gain photomultiplier impulse response functionsK D Meaney, J Jeet, J Carrera, et al.
International Immunology|April 28, 2000
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigensK Tani, W J Murphy, O Chertov, et al.
Neuropathology and Applied Neurobiology|August 7, 2020
Plectin-related scapuloperoneal myopathy with treatment-responsive myasthenic syndromeH Argente-Escrig, D Schultheis, L Kamm, et al.
Leukemia|October 17, 2003
Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trialG Buesche, R Hehlmann, H Hecker, et al.
The Review of Scientific Instruments|August 2, 2013
Monte Carlo validation experiments for the gas Cherenkov detectors at the National Ignition Facility and OmegaM S Rubery, C J Horsfield, H Herrmann, et al.
Rheumatology International|June 1, 2017
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and CanadaLaure Weijers, Christoph Baerwald, Francesco S Mennini, et al.
Journal of Clinical Epidemiology|August 19, 2023
GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendationsFeng Xie, Ian Shemilt, Luke Vale, et al.
European Journal of Clinical Investigation|March 27, 2009
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cellsA Böhm, K J Aichberger, M Mayerhofer, et al.
The Review of Scientific Instruments|May 3, 2015
Simultaneous neutron and x-ray imaging of inertial confinement fusion experiments along a single line of sight at OmegaC R Danly, T H Day, D N Fittinghoff, et al.
Current Cancer Drug Targets|December 15, 2011
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann, M Kneidinger, S Cerny-Reiterer, et al.
Pageof 48

Showing results (451-460 of 477) with videos related to

Sort By:
Pageof 48
The Review of Scientific Instruments|December 2, 2024
Inferring fusion nuclear burnwidths with low gain photomultiplier impulse response functionsK D Meaney, J Jeet, J Carrera, et al.
International Immunology|April 28, 2000
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigensK Tani, W J Murphy, O Chertov, et al.
Neuropathology and Applied Neurobiology|August 7, 2020
Plectin-related scapuloperoneal myopathy with treatment-responsive myasthenic syndromeH Argente-Escrig, D Schultheis, L Kamm, et al.
Leukemia|October 17, 2003
Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trialG Buesche, R Hehlmann, H Hecker, et al.
The Review of Scientific Instruments|August 2, 2013
Monte Carlo validation experiments for the gas Cherenkov detectors at the National Ignition Facility and OmegaM S Rubery, C J Horsfield, H Herrmann, et al.
Rheumatology International|June 1, 2017
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and CanadaLaure Weijers, Christoph Baerwald, Francesco S Mennini, et al.
Journal of Clinical Epidemiology|August 19, 2023
GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendationsFeng Xie, Ian Shemilt, Luke Vale, et al.
European Journal of Clinical Investigation|March 27, 2009
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cellsA Böhm, K J Aichberger, M Mayerhofer, et al.
The Review of Scientific Instruments|May 3, 2015
Simultaneous neutron and x-ray imaging of inertial confinement fusion experiments along a single line of sight at OmegaC R Danly, T H Day, D N Fittinghoff, et al.
Current Cancer Drug Targets|December 15, 2011
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann, M Kneidinger, S Cerny-Reiterer, et al.
Pageof 48